Overview

The STREAM Percutaneous Coronary Intervention Anticoagulant Sub-study

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of Enoxaparin and Unfractionated Heparin in St Elevation Myocardial Infarction patients undergoing primary percutaneous coronary intervention.
Phase:
Phase 3
Details
Lead Sponsor:
Robert Welsh
Collaborators:
Boehringer Ingelheim
Sanofi
Treatments:
Calcium heparin
Enoxaparin
Heparin